TRENDS IN THE INCIDENCE OF ROTAVIRUS INFECTION AND ASSESSMENT OF ITS VACCINATION BY THE EXAMPLE OF THE MOSCOW REGION

Download full text PDF
Issue: 
8
Year: 
2017

Professor L. Feklisova (1), MD; R. Shapovalova (2) 1-M.F. Vladimirsky Moscow Regional Clinical Research Institute 2-Podolsk Territorial Directorate for the Moscow Region, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare

The safety and efficiency of immunization against rotavirus infection were evaluated based on a long-term analysis of the incidence of enteric infections, by using one of the areas of the Moscow region as an example. The paper provides data on the dominance of rotavirus enteritis in the etiological structure of acute enteric infections. The genotypes of rotaviruses matching to pentavalent RotaTeq® vaccine strains were found to circulate. Immunization in 46.5% of babies in the first year of life during the first year of vaccination and in 69.4% during the second year contributed to reductions in the incidence of rotavirus infection in all age groups and in the number of hospitalized patients aged 0-6 years.
Keywords: 
infectious diseases
rotavirus infection
vaccination
incidence

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Vaktsinoprofilaktika rotavirusnoj infektsii u detej: Federal'nye klin. rekomendatsii. Minzdrav Rossii, Sojuz pediatrov Rossii / M.: Pediatr, 2016; 40 s.
  2. Velázquez F. et al. Rotavirus Infection in Infants as Protection against Subsequent Infections // N. Engl. J. Med. – 1996; 335: 1022–8.
  3. Tate J., Burton A., Boschi-Pinto C. et al. 2008 estimate of worldwide rotavirus associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis // Lancet. Infect. Dis. – 2012; 12: 136–41.
  4. O sostojanii sanitarno-epidemiologicheskogo blagopoluchija naselenija v Rossijskoj Federatsii v 2015 godu. Gosudarstvennyj doklad / M.: Federal'naja sluzhba po nadzoru v sfere zaschity prav potrebitelej i blagopoluchija cheloveka, 2016; 200 s.
  5. Tatochenko V.K. Vaktsinoprofilaktika rotavirusnoj infektsii // Med. sovet. – 2016; 7: 36–8.
  6. O sostojanii sanitarno-epidemiologicheskogo blagopoluchija naselenija v Rossijskoj Federatsii v 2016 godu. Gosudarstvennyj doklad / M.: Federal'naja sluzhba po nadzoru v sfere zaschity prav potrebitelej i blagopoluchija cheloveka, 2017; 220 s.
  7. Podkolzin A. et al. Hospital-Based Surveillance of Rotavirus and Other Viral Agents of Diarrhea in Children and Adults in Russia, 2005–2007 // JID. – 2009; 200 (1): 228–33.
  8. Veselova O. et al. Rotavirus Group A Surveillance and Genotype Distribution in Russian Federation in Seasons 2012–2013 // Int. J. Clin. Med. – 2014; 5: 407–13.
  9. Lobzin Y. et al. Burden of Childhood Rotavirus Disease in the Outpatient Setting of the Russian Federation // Pediatr. Infect. Dis. J. – 2016; DOI: 10.1097/INF.0000000000001472. [Epub ahead of print].
  10. Luk'janova A.M. i dr. Kliniko-epidemiologicheskaja harakteristika virusnyh diarej u detej // Zhurn. infektol. – 2014; 6 (1): 60–6.
  11. Gleizes O. et al. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease // Pediatr. Infect. Dis. J. – 2006; 25 (1 Suppl.): 12–21.
  12. Evroaziatskoe obschestvo po infektsionnym boleznjam, mezhregional'naja obschestvennaja organizatsija «Assotsiatsija vrachej». Klin. rekomendatsii (protokol lechenija) okazanija meditsinskoj pomoschi detjam, bol'nym rotavirusnoj infektsiej / SPb, 2014.
  13. Foppa I. et al. Health care-associated rotavirus illness in pediatric inpatients in Germany, Austria, and Switzerland // Infect. Control Hosp. Epidemiol. – 2006; 27: 633–5.
  14. Feklisova L.V., Shapovalova R.F., Lihanskaja E.I. i dr. Ekskretsija rotavirusov v fekalijah patsientov pediatricheskih statsionarov v techenie goda // Vrach. – 2016; 10: 77–82.
  15. Rotavirusnye vaktsiny. Dokument po pozitsii VOZ; janvar' 2013 g. – 1 fevralja 2013 g. – 1988; 5 // Ezhenedel'nyj epidemiol. bjul. – 2013; 88: 49–64. URL: http://www.who.int/wer
  16. Vesikari T., Matson D., Dennehy P. et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine // N. Engl. J. Med. – 2006; 354 (1): 23–33.
  17. WHO vaccine-preventable diseases: monitoring system. 2016 global summary. Dostupno po adresu: http://apps.who.int/immunization_monitoring/globalsummary/schedules (Dostup 01.04.2017).
  18. Tate J., Parashar U. Rotavirus Vaccines in Routine Use // CID. – 2014; 59: 1291–301.
  19. Lopman B. et al. Infant Rotavirus Vaccination May Provide Indirect Protection to Older Children and Adults in the United States // J. Infect. Dis. – 2011; 204 (7): 980–6.
  20. Hartwig S. et al. Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq® // BMC Health Services Research. – 2014; 14: 632.
  21. Wendy B. Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): impact on the timeliness of uptake of the primary course of DTPa vaccine // Vaccine. – 2012; 30 (35): 5293–7.
  22. Prikaz Minzdrava Rossii ot 21 marta 2014 g. №125n (Moskva) «Ob utverzhdenii natsional'nogo kalendarja profilakticheskih privivok i kalendarja profilakticheskih privivok po epidemicheskim pokazanijam».
  23. Martynova G.P., Juzhakova A.G. i dr. Rotavirusnaja infektsija u detej v Krasnojarskom krae: pervye shagi k snizheniju zabolevaemosti // Farmateka. – 2016; 11: 1–6.
  24. Rychkova O.A. i dr. Profilaktika rotavirusnoj infektsii: put' rasshirenija regional'noj programmy vaktsinatsii Tjumenskoj oblasti // Farmateka. – 2016; 11: 7–12.
  25. Instruktsija po meditsinskomu primeneniju lekarstvennogo preparata RotaTek®.